 Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009, and shipped about 80 million doses to over 60 countries.Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.The company has launched the generic version of experimental COVID-19 drug "Remdesivir" after acquiring license from Gilead Sciences and obtaining approval from CDSCO, the Indian drug control authority.